Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

IN THE GRAND COURT OF THE CAYMAN ISLANDS

FINANCIAL SERVICES DIVISION

CAUSE NO. FSD 167 OF 2020

IN THE MATTER OF SECTIONS

15 AND 86 OF THE COMPANIES LAW (2020 REVISION)

AND IN THE MATTER OF ORDER 102 OF

THE GRAND COURT RULES 1995 AND IN THE MATTER OF GOLDEN MEDITECH HOLDINGS LIMITED 金衛醫療集團有限公司

NOTICE OF COURT MEETING

NOTICE IS HEREBY GIVEN that, by an order dated 13 August 2020 (the ''Order'') made in the above matter, the Grand Court of the Cayman Islands (the ''Court'') has directed a meeting (the ''Court Meeting'') to be convened of holders of ordinary shares of par value HK$0.20 each in the capital of Golden Meditech Holdings Limited 金衛醫療集 團有限公司 (the ''Company'') other than the Offeror and the Offeror Concert Parties, all of which are defined in the composite scheme document, of which this Notice forms part (the ''Holders''), for the purpose of considering and, if thought fit, approving, with or without modifications, a scheme of arrangement (the ''Scheme'') proposed to be made between the Company and the Scheme Shareholders (as defined in the Scheme) and that the Court Meeting will be held at Nathan Room, Lower Lobby, Conrad Hong Kong, Pacific Place, 88 Queensway, Hong Kong on Wednesday, 16 September 2020 at 2 : 00 p.m. (Hong Kong time) (see Note) at which place and time all such Holders are requested to attend. A copy of the Scheme and a copy of an explanatory memorandum explaining the effect of the Scheme are incorporated in the composite scheme document of which this Notice forms part.

A copy of the composite scheme document can also be obtained by the Holders from the Company's branch share registrar and transfer office in Hong Kong, Computershare Hong Kong Investor Services Limited, at 17M Floor, Hopewell Centre, 183 Queen's Road East, Wanchai, Hong Kong.

- 1 -

Such Holders may vote in person at the Court Meeting or they may appoint one or more other persons (who each must be an individual), whether a member of the Company or not, to attend and vote in their stead. A pink form of proxy for use at the Court Meeting is enclosed with the composite scheme document dated Friday, 21 August 2020 despatched to members of the Company on Friday, 21 August 2020.

In the case of joint holders of a share, any one of such persons may vote at the Court Meeting, either personally or by proxy, in respect of such share as if he were solely entitled thereto. However, if more than one of such joint holders be present at the Court Meeting personally or by proxy, that one of the said persons so present being the most or, as the case may be, the more senior shall alone be entitled to vote in respect of the relevant joint holding. For this purpose, seniority shall be determined by reference to the order in which the names of the joint holders stand on the register of members of the Company in respect of such joint holding, the first named shareholder being the senior.

It is requested that the duly completed pink form of proxy be deposited at the Company's branch share registrar and transfer office in Hong Kong, Computershare Hong Kong Investor Services Limited, at 17M Floor, Hopewell Centre, 183 Queen's Road East, Wanchai, Hong Kong (the ''Registration Office''), not later than 2 : 00 p.m. (Hong Kong time) on Monday, 14 September 2020 or alternatively, be handed to the Chairman of the Court Meeting at the Court Meeting (who shall have absolute discretion as to whether or not to accept it). Completion and return of the proxy form will not preclude any member from attending and voting in person at the Court Meeting. In the event that a member of the Company attends the meeting and vote in person after having lodged his pink form of proxy, the pink form of proxy will be deemed to have been revoked. A vote given in accordance with the terms of an instrument of proxy shall be valid notwithstanding the previous death or insanity of the principal, or revocation of the instrument of proxy or of the authority under which it was executed, provided that no intimation in writing of such death, insanity or revocation shall have been received by the Company at the Registration Office at least two (2) hours before the commencement of the Court Meeting or any adjourned meeting at which the proxy is used.

Please refer to the ''Part II. Actions To be Taken - Precautionary Measures for the Court Meeting and the General Meeting'' of the composite scheme document for precautionary measures being implemented by the Company in order to prevent and control the spread of the novel coronavirus (COVID-19) and to ensure the health and safety of all attendees at the Court Meeting, including (i) compulsory body temperature checks; (ii) compulsory wearing of surgical face masks for each attendee; and (iii) limiting attendance at the Court Meeting. Any person who does not comply with the precautionary measures or is subject to any Hong Kong Government prescribed quarantine may be denied entry into and/or may be required to leave the venue of the Court Meeting.

- 2 -

Shareholders are encouraged to consider appointing the chairman of the Court Meeting as his/her/its proxy to vote on the relevant resolution(s) at the Court Meeting as an alternative to attending the Court Meeting in person.

By the Order, the Court has appointed Mr. Feng Wen, director, or failing him, Mr. Leong Kim Chuan, director, or failing him, any other director of the Company, to act as the Chairman of the Court Meeting and has directed the Chairman of the Court Meeting to report the results of the Court Meeting to the Court.

The Scheme will be subject to a subsequent application seeking the sanction of the Court.

By Order of the Court

Golden Meditech Holdings Limited

金衛醫療集團有限公司

Note: In the event that a tropical cyclone warning signal no. 8 or above is hoisted or a black rainstorm warning signal is in force at 8 : 00 a.m. on Wednesday, 16 September 2020, the Court Meeting will be adjourned to Friday, 18 September 2020 at 2 : 00 p.m. or at a time on an alternative day to be announced that falls within fourteen days of the original date scheduled for the Court Meeting. You may call the hotline at +852 3605 8180 during business hours from 9 : 00 a.m. to 5 : 00 p.m. on Monday to Friday, excluding public holidays or visit the website of the Company at www.goldenmeditech.com. for details of alternative meeting arrangements. The Court Meeting will be held as scheduled even when a tropical cyclone warning signal no. 3 or below is hoisted or an amber or red rainstorm warning signal is in force.

You should make your own decision as to whether you would attend the Court Meeting under bad weather conditions bearing in mind your own situation and if you should choose to do so, you are advised to exercise care and caution.

Dated 21 August 2020

Registered office:

Principal place of business

P.O. Box 1350

in Hong Kong:

Clifton House

48th Floor, Bank of China Tower

75 Fort Street

1 Garden Road

Grand Cayman KY1-1108

Central

Cayman Islands

Hong Kong

As at the date of this announcement, the Board comprises five Directors. The executive Directors are Mr. Feng Wen (Chairman) and Mr. Leong Kim Chuan (Chief Executive); and the independent non-executive Directors are Mr. Gao Yue, Mr. Poon Tsz Hang and Mr. Daniel Foa.

- 3 -

Attachments

  • Original document
  • Permalink

Disclaimer

Golden Meditech Holding Limited published this content on 20 August 2020 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 20 August 2020 10:20:10 UTC